# Outdoor Holding Co: financial statements, quarterly

POWW · Nasdaq · CIK 1015383 · [Industrials](/sectors/industrials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/poww.md) · [Financials](/companies/poww/financials.md) · [Filings](/companies/poww/filings.md) · [Insiders](/companies/poww/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/poww/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [34.4](/filings/0000950170-25-075258.md) | [36.0](/filings/0000950170-25-075310.md) | [40.4](/filings/0000950170-25-075182.md) | [12.3](/filings/0000950170-25-105988.md) | [12.0](/filings/0001193125-25-273158.md) | [12.5](/filings/0001193125-26-041880.md) | [12.6 d](/filings/0001193125-26-276653.md) | [11.9](/filings/0001193125-26-341113.md) | [12.0](/filings/0001193125-25-273158.md) | [13.4](/filings/0001193125-26-041880.md) | [13.9 d](/filings/0001193125-26-276653.md) | [14.5](/filings/0001193125-26-341113.md) |
| Cost of revenue | $m | [26.1](/filings/0000950170-25-075258.md) | [25.1](/filings/0000950170-25-075310.md) | [31.0](/filings/0000950170-25-075182.md) | [1.7](/filings/0000950170-25-105988.md) | [1.6](/filings/0001193125-25-273158.md) | [1.6](/filings/0001193125-26-041880.md) | [1.6 d](/filings/0001193125-26-276653.md) | [1.5](/filings/0001193125-26-341113.md) | [1.5](/filings/0001193125-25-273158.md) | [1.7](/filings/0001193125-26-041880.md) | [1.7 d](/filings/0001193125-26-276653.md) | [2.2](/filings/0001193125-26-341113.md) |
| Gross profit | $m | [8.3](/filings/0000950170-25-075258.md) | [10.9](/filings/0000950170-25-075310.md) | [9.4](/filings/0000950170-25-075182.md) | [10.5](/filings/0000950170-25-105988.md) | [10.4](/filings/0001193125-25-273158.md) | [11.0](/filings/0001193125-26-041880.md) | [11.0 d](/filings/0001193125-26-276653.md) | [10.3](/filings/0001193125-26-341113.md) | [10.4](/filings/0001193125-25-273158.md) | [11.7](/filings/0001193125-26-041880.md) | [12.2 d](/filings/0001193125-26-276653.md) | [12.2](/filings/0001193125-26-341113.md) |
| Selling, general and administrative | $m | [13.9](/filings/0000950170-25-075258.md) | [10.1](/filings/0000950170-25-075310.md) | [12.0 d](/filings/0000950170-25-075182.md) | [16.8](/filings/0000950170-25-075209.md) | [16.3](/filings/0000950170-25-075258.md) | [30.5](/filings/0000950170-25-075310.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(9.0)](/filings/0000950170-25-075258.md) | [(2.6)](/filings/0000950170-25-075310.md) | [(6.0)](/filings/0000950170-25-075182.md) | [(6.2)](/filings/0000950170-25-105988.md) | [(6.0)](/filings/0001193125-25-273158.md) | [(20.5)](/filings/0001193125-26-041880.md) | [(26.9) d](/filings/0001193125-26-276653.md) | [(6.0)](/filings/0001193125-26-341113.md) | [0.7](/filings/0001193125-25-273158.md) | [2.0](/filings/0001193125-26-041880.md) | [(3.0) d](/filings/0001193125-26-276653.md) | [3.3](/filings/0001193125-26-341113.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(1.9)](/filings/0000950170-25-075258.md) | [(0.4)](/filings/0000950170-25-075310.md) | [(1.4)](/filings/0000950170-25-075182.md) | [6.0](/filings/0000950170-25-105988.md) | [0.0](/filings/0000950170-25-075258.md) | [0.0](/filings/0000950170-25-075310.md) | [0.3 d](/filings/0001193125-26-276653.md) | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-341113.md) |
| Net income | $m | [(7.7)](/filings/0000950170-25-075310.md) | [(2.4)](/filings/0000950170-25-075310.md) | [(5.2)](/filings/0000950170-25-075182.md) | [(14.8)](/filings/0001193125-26-041880.md) | [(12.4)](/filings/0001193125-26-041880.md) | [(26.1)](/filings/0001193125-26-041880.md) | [(77.5) d](/filings/0001193125-26-276653.md) | [(6.5)](/filings/0001193125-26-341113.md) | [1.4](/filings/0001193125-26-041880.md) | [2.2](/filings/0001193125-26-041880.md) | [(0.7) d](/filings/0001193125-26-276653.md) | [3.6](/filings/0001193125-26-341113.md) |
| Diluted EPS | $ per share | [(0.07)](/filings/0000950170-25-075258.md) | [(0.03)](/filings/0000950170-25-075310.md) | [(0.05)](/filings/0000950170-25-075182.md) | [(0.13)](/filings/0000950170-25-105988.md) | [(0.11)](/filings/0001193125-25-273158.md) | [(0.23)](/filings/0001193125-26-041880.md) | not reported | [(0.06)](/filings/0001193125-26-341113.md) | [0.01](/filings/0001193125-25-273158.md) | [0.01](/filings/0001193125-26-041880.md) | not reported | [0.02](/filings/0001193125-26-341113.md) |
| Basic EPS | $ per share | [(0.07)](/filings/0000950170-25-075258.md) | [(0.03)](/filings/0000950170-25-075310.md) | [(0.05)](/filings/0000950170-25-075182.md) | [(0.13)](/filings/0000950170-25-105988.md) | [(0.11)](/filings/0001193125-25-273158.md) | [(0.23)](/filings/0001193125-26-041880.md) | not reported | [(0.06)](/filings/0001193125-26-341113.md) | [0.01](/filings/0001193125-25-273158.md) | [0.01](/filings/0001193125-26-041880.md) | not reported | [0.02](/filings/0001193125-26-341113.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [49.6](/filings/0000950170-25-075182.md) | [54.7](/filings/0000950170-25-075182.md) | [55.6](/filings/0000950170-25-086893.md) | [50.8](/filings/0000950170-25-075209.md) | [33.5](/filings/0000950170-25-075258.md) | [31.9](/filings/0000950170-25-075310.md) | [30.2](/filings/0001193125-26-276653.md) | [63.4](/filings/0000950170-25-105988.md) | [65.7](/filings/0001193125-25-273158.md) | [69.9](/filings/0001193125-26-041880.md) | [68.1](/filings/0001193125-26-341113.md) | [68.8](/filings/0001193125-26-341113.md) |
| Current assets | $m | [130](/filings/0000950170-25-075182.md) | [129](/filings/0000950170-25-075182.md) | [132](/filings/0000950170-25-086893.md) | [134](/filings/0000950170-25-075209.md) | [109](/filings/0000950170-25-075258.md) | [98.8](/filings/0000950170-25-075310.md) | [72.1](/filings/0001193125-26-276653.md) | [74.5](/filings/0000950170-25-105988.md) | [78.3](/filings/0001193125-25-273158.md) | [82.5](/filings/0001193125-26-041880.md) | [82.0](/filings/0001193125-26-341113.md) | [82.2](/filings/0001193125-26-341113.md) |
| Total assets | $m | [406](/filings/0000950170-25-075182.md) | [404](/filings/0000950170-25-075182.md) | [403](/filings/0000950170-25-086893.md) | [399](/filings/0000950170-25-075209.md) | [369](/filings/0000950170-25-075258.md) | [355](/filings/0000950170-25-075310.md) | [297](/filings/0001193125-26-276653.md) | [269](/filings/0000950170-25-105988.md) | [270](/filings/0001193125-25-273158.md) | [272](/filings/0001193125-26-041880.md) | [267](/filings/0001193125-26-341113.md) | [265](/filings/0001193125-26-341113.md) |
| Current liabilities | $m | [27.7](/filings/0000950170-25-075182.md) | [26.7](/filings/0000950170-25-075182.md) | [31.0](/filings/0000950170-25-086893.md) | [42.3](/filings/0000950170-25-075209.md) | [29.8](/filings/0000950170-25-075258.md) | [42.4](/filings/0000950170-25-075310.md) | [62.1](/filings/0001193125-26-276653.md) | [22.7](/filings/0000950170-25-105988.md) | [22.7](/filings/0001193125-25-273158.md) | [20.7](/filings/0001193125-26-041880.md) | [20.7](/filings/0001193125-26-341113.md) | [17.3](/filings/0001193125-26-341113.md) |
| Total liabilities | $m | [41.0](/filings/0000950170-25-075182.md) | [40.9](/filings/0000950170-25-075182.md) | [45.0](/filings/0000950170-25-086893.md) | [56.1](/filings/0000950170-25-075209.md) | [43.4](/filings/0000950170-25-075258.md) | [55.8](/filings/0000950170-25-075310.md) | [75.3](/filings/0001193125-26-276653.md) | [47.0](/filings/0000950170-25-105988.md) | [34.9](/filings/0001193125-25-273158.md) | [34.4](/filings/0001193125-26-041880.md) | [32.5](/filings/0001193125-26-341113.md) | [28.6](/filings/0001193125-26-341113.md) |
| Long-term debt | $m | not reported | [20.0](/filings/0001493152-24-023731.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [365](/filings/0000950170-25-075310.md) | [363](/filings/0000950170-25-075310.md) | [358](/filings/0001193125-26-276653.md) | [342](/filings/0001193125-26-041880.md) | [326](/filings/0001193125-26-041880.md) | [300](/filings/0001193125-26-041880.md) | [222](/filings/0001193125-26-341113.md) | [223](/filings/0001193125-26-341113.md) | [235](/filings/0001193125-26-041880.md) | [237](/filings/0001193125-26-041880.md) | [235](/filings/0001193125-26-341113.md) | [236](/filings/0001193125-26-341113.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [5.2 d](/filings/0000950170-25-075258.md) | [10.2 d](/filings/0000950170-25-075310.md) | [4.3 d](/filings/0000950170-25-075182.md) | [(0.5)](/filings/0000950170-25-075209.md) | [(9.3) d](/filings/0000950170-25-075258.md) | [1.3 d](/filings/0000950170-25-075310.md) | [3.6 d](/filings/0001193125-26-276653.md) | [(6.7)](/filings/0001193125-26-341113.md) | [3.2 d](/filings/0001193125-25-273158.md) | [5.7 d](/filings/0001193125-26-041880.md) | [(1.3) d](/filings/0001193125-26-276653.md) | [4.4](/filings/0001193125-26-341113.md) |
| Capital expenditure | $m | [1.3 d](/filings/0000950170-25-075258.md) | [2.9 d](/filings/0000950170-25-075310.md) | [(2.9) d](/filings/0000950170-25-086893.md) | [0.8](/filings/0000950170-25-105988.md) | [1.2 d](/filings/0001193125-25-273158.md) | [0.5 d](/filings/0001193125-26-041880.md) | [0.8 d](/filings/0001193125-26-276653.md) | [0.9](/filings/0001193125-26-341113.md) | [0.7 d](/filings/0001193125-25-273158.md) | [0.6 d](/filings/0001193125-26-041880.md) | [0.7 d](/filings/0001193125-26-276653.md) | [0.7](/filings/0001193125-26-341113.md) |
| Share repurchases | $m | [1.9 d](/filings/0000950170-25-075182.md) | [0.3 d](/filings/0000950170-25-075310.md) | [0.0 d](/filings/0000950170-25-075182.md) | [0.4](/filings/0000950170-25-105988.md) | [0.1 d](/filings/0001193125-25-273158.md) | [0.1 d](/filings/0001193125-26-041880.md) | [0.1 d](/filings/0001193125-26-276653.md) | [0.2](/filings/0001193125-26-341113.md) | [0.0 d](/filings/0001193125-25-273158.md) | [0.1 d](/filings/0001193125-26-041880.md) | [0.1 d](/filings/0001193125-26-276653.md) | [0.1](/filings/0001193125-26-341113.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities, us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [117](/filings/0001493152-23-040071.md) | [117](/filings/0001493152-24-005477.md) | [118](/filings/0000950170-25-075209.md) | [118](/filings/0000950170-25-075258.md) | [118](/filings/0000950170-25-075310.md) | [119](/filings/0000950170-25-105988.md) | [119](/filings/0001193125-25-273158.md) | [116](/filings/0001193125-26-041880.md) | [117](/filings/0001193125-26-341113.md) | [118](/filings/0001193125-25-273158.md) | [123](/filings/0001193125-26-041880.md) | [124](/filings/0001193125-26-341113.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 116,015,357 at 2026-08-05, from the cover of the [10-Q filed 2026-08-10](/filings/0001193125-26-341113.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.